Ebola: Africa’s
Recurring Emergency
The 17th outbreak in DRC since 1976 is now a global health emergency. A cure exists in Germany while Congolese patients die without access to it. DOGE cut the surveillance systems that could have caught this earlier. And the same question keeps being asked: when will Africa build the infrastructure to protect its own people?
This is the defining injustice of the 2026 Ebola outbreak — and every outbreak before it. The world knows how to manage Ebola. It simply has not bothered to build that capacity where Ebola actually kills people.
DRC’s 17th Outbreak — and Why This One Is Different
On 15 May 2026, the Ministry of Health of the Democratic Republic of the Congo confirmed an outbreak of Ebola disease in Ituri Province, northeastern DRC. Within 48 hours, the World Health Organization declared it a Public Health Emergency of International Concern (PHEIC) — its highest level of alarm. Africa CDC declared a Public Health Emergency of Continental Security the following day.
What makes this outbreak particularly alarming is the strain: Bundibugyo virus (BDBV) — a species of Ebola for which there is currently no approved vaccine and no specific treatment. The two approved treatments that transformed survival rates in previous outbreaks — Inmazeb and Ebanga — work only against the Zaire strain. Against Bundibugyo, doctors are working with supportive care alone.
The outbreak has already crossed an international border. A case was confirmed in Uganda’s capital Kampala, prompting a Level 1 travel health notice for Uganda and a Level 3 notice for DRC. Cases have now been confirmed in Ituri, North Kivu, and South Kivu provinces — three of DRC’s most volatile, conflict-affected, and mobile-population regions.
The Bundibugyo virus is believed to have circulated undetected for six to eight weeks before laboratory confirmation. Local tests in Bunia initially returned negative results because they were testing for the more common Zaire strain. This diagnostic gap — a direct consequence of under-resourced surveillance infrastructure — allowed the outbreak to reach scale before any containment response could begin.
DRC’s Ebola History — 17 Outbreaks Since 1976
The Democratic Republic of the Congo has experienced more Ebola outbreaks than any other country on earth. This is not coincidence — it is the predictable consequence of under-investment in health infrastructure, persistent conflict, and a virus that lives in the forests surrounding some of the DRC’s most populated provinces.
| Year | Province / Location | Strain | Cases | Deaths | CFR |
|---|
How DOGE Dismantled the Early Warning System
When the Bundibugyo strain circulated undetected in northeastern DRC for six to eight weeks before any laboratory confirmation, the question was not only medical. It was political. Because the surveillance systems that should have caught this outbreak earlier were systematically dismantled in 2025 — by the United States Department of Government Efficiency.
In February 2025, Elon Musk — then leading DOGE — admitted publicly in a Cabinet meeting that his agency had “accidentally” cancelled Ebola prevention funding. “I think we all want Ebola prevention,” he said. “So we restored the Ebola prevention immediately, and there was no interruption.” Subsequent reporting told a very different story.
The Washington Post confirmed that USAID’s Ebola prevention efforts had been “largely halted” after DOGE moved to dismantle the global assistance agency. A State Department spokesperson disputed this, saying “funding and support to combat Ebola continue.” But the Bundibugyo virus spent two months spreading undetected through a region that once had some of the most sophisticated outbreak surveillance on the continent. The evidence speaks.
The lesson for Africa is not that America’s withdrawal is irreversible. The lesson is that Africa’s public health architecture cannot be built on donor dependency. When the donor cuts its budget, African people die. That dependency — not just the virus — is the emergency that needs to end.
The Response Has Dramatically Improved — For Those With Access
The story of Ebola response between 1976 and 2026 is genuinely one of medical progress. Fatality rates that once reached 90% have been reduced. Vaccines exist. Two approved treatments have been shown in randomised controlled trials to cut mortality by nearly half. Surveillance systems, when funded, can detect outbreaks within days. The question is not whether humanity knows how to respond to Ebola. It does. The question is whether that knowledge reaches the people who need it.
The 2018–2020 outbreak in North Kivu and Ituri — the second largest in Ebola history — was eventually contained, in part because of the deployment of the rVSV-ZEBOV vaccine (Ervebo) in a ring vaccination strategy, and the use of the new monoclonal antibody treatments. Case fatality rates among those who received both vaccination and monoclonal antibody therapy were significantly lower than historical averages. This was, quietly, one of the most significant public health achievements of the 21st century.
But that progress applies to the Zaire strain. The 2026 Bundibugyo outbreak is a reminder that Ebola is not one virus. It is a family — and the treatments developed for Zaire do not protect against Bundibugyo, Sudan, or other species. The work is not done.
From No Treatment to Approved Therapies — The Science Story
In 1976, when Ebola was first identified along the Ebola river in DRC, there was no treatment, no vaccine, and no real understanding of how to stop it. Fifty years later, the picture has transformed — at least for the Zaire strain.
Flown to Germany: The Doctor Who Got the Care DRC Patients Cannot
On 20 May 2026, an ambulance convoy arrived at Charité University Hospital in Berlin carrying Dr Peter Stafford, an American missionary surgeon who had contracted the Bundibugyo strain of Ebola while operating on a patient at Nyankunde Hospital near Bunia, DRC. He had performed surgery on a 33-year-old patient with severe abdominal pain — days before the Africa CDC confirmed the outbreak. Standard surgical PPE — gowns, gloves, a mask — was not enough.
Dr Stafford and his wife, Dr Rebekah Stafford — also a physician who had treated the same patient — were airlifted with their four children to Berlin. As of 22 May 2026, Dr Stafford was not critically ill, in close observation in Charité’s high-security isolation unit. His wife and children all tested negative.
It is not a criticism of Dr Stafford — a man who gave years of his life serving patients in one of the world’s most difficult healthcare environments — that this disparity exists. It is a question for every government, every donor, and every African institution that has accepted this inequality as the natural order of things. Why is there no Charité-equivalent isolation unit in Bunia? In Goma? In Kinshasa?
What Africa Must Ask — And Build
After 50 years and 17 outbreaks in one country alone, the time for asking questions has long passed. But since the questions are still not being asked loudly enough — here they are.
Build the Hospital in DRC. Now. Not After the Next Outbreak.
The African Union has the mandate. The African Development Bank has the financing capacity. The continent’s heads of state have, year after year, signed declarations committing to health infrastructure investment. And yet, in 2026, when the 17th Ebola outbreak in DRC is declared a global health emergency, the nearest high-security isolation unit equipped to manage Bundibugyo virus disease patients is in Berlin, Germany.
This is not acceptable.
TGRI calls on the African Union to commission and fund, as a matter of continental priority, a dedicated high-level infectious disease treatment and research centre in eastern DRC — in Bunia, Goma, or a location accessible to the provinces where Ebola outbreaks consistently originate. This facility should meet or exceed the standards of Charité’s Specialised Isolation Unit. It should serve the DRC, Uganda, South Sudan, Rwanda, and the Great Lakes region as a permanent regional resource.
The facility should be built and operated under African Union and Africa CDC governance — not as a donor-dependent project, but as a sovereign continental asset. It should train African infectious disease specialists, manufacture and stockpile vaccines and therapeutics domestically, and serve as the continent’s primary centre of excellence for haemorrhagic fever research. It should have the diagnostic capacity to identify not just Zaire Ebola, but Bundibugyo, Sudan virus, Marburg, and every other pathogen circulating in equatorial Africa’s forests.
Fifty years of outbreaks. Fifty years of international responders landing in DRC. Fifty years of evacuation flights to European hospitals for those fortunate enough to hold the right passport. Fifty years is long enough. The 18th outbreak will come. The only question is what Africa will have built before it does.
Leave a Reply